Lin, Richard J <br/><br/>
Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma.  [electronic resource] 

 -  Haematologica  01 2021 
 - 255-258 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Standard No.: </label>10.3324/haematol.2019.243246  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antigens, CD19<br/>Cell- and Tissue-Based Therapy<br/>Humans<br/>Immunotherapy, Adoptive<br/>Lymphoma, Large B-Cell, Diffuse--therapy<br/>Receptors, Antigen, T-Cell--genetics<br/>Receptors, Chimeric Antigen--genetics